Albert T A Mairuhu
Overview
Explore the profile of Albert T A Mairuhu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
983
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Luijten D, van den Hout W, Boon G, Barco S, Bogaard H, Delcroix M, et al.
ERJ Open Res
. 2025 Jan;
11(1.
PMID: 39811556
Introduction: Achieving an early diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH) in pulmonary embolism (PE) survivors results in better quality of life and survival. Importantly, dedicated follow-up strategies to achieve...
2.
Kist J, Vos H, Vos R, Mairuhu A, Struijs J, Vermeiren R, et al.
Int J Epidemiol
. 2024 Jul;
53(4).
PMID: 39049713
No abstract available.
3.
Luijten D, Valerio L, Boon G, Barco S, Bogaard H, Delcroix M, et al.
Eur Respir J
. 2024 Jun;
64(4).
PMID: 38936968
Introduction: Chronic thromboembolic pulmonary hypertension (CTEPH) is often diagnosed late in acute pulmonary embolism survivors: more efficient testing to expedite diagnosis may considerably improve patient outcomes. The InShape II algorithm...
4.
Burggraaf-van Delft J, van Rein N, Bemelmans R, van den Berg J, Bruggeman C, Cloos-van Balen M, et al.
BMJ Open
. 2024 Mar;
14(3):e078676.
PMID: 38521524
Introduction: Patients with a first venous thromboembolism (VTE) are at risk of recurrence. Recurrent VTE (rVTE) can be prevented by extended anticoagulant therapy, but this comes at the cost of...
5.
Kaptein F, Guman N, Lohle S, Klok F, Mairuhu A, Kamphuisen P, et al.
TH Open
. 2024 Feb;
8(1):e61-e71.
PMID: 38298199
Current guidelines recommend either low-molecular weight heparin (LMWH) or direct oral anticoagulants (DOACs) as first-line treatment in cancer-associated venous thromboembolism (VTE). This study aimed to investigate treatment regimens for cancer-associated...
6.
de Jong C, van den Hout W, van Dijk C, Heim N, van Dam L, Dronkers C, et al.
Thromb Haemost
. 2023 Nov;
124(6):557-567.
PMID: 37984402
Background: The diagnosis of recurrent ipsilateral deep vein thrombosis (DVT) with compression ultrasonography (CUS) may be hindered by residual intravascular obstruction after previous DVT. A reference CUS, an additional ultrasound...
7.
Stals M, Beenen L, Coppens M, Faber L, Hofstee H, Hovens M, et al.
Thromb Res
. 2023 Oct;
231:65-75.
PMID: 37816274
Background: The recently published 4-level Pulmonary Embolism Clinical Probability Score (4PEPS) integrates different aspects from currently available diagnostic strategies to further reduce imaging testing in patients with clinically suspected pulmonary...
8.
Luijten D, Talerico R, Barco S, Cannegieter S, Delcroix M, Ende-Verhaar Y, et al.
Eur Respir J
. 2023 Jun;
62(1).
PMID: 37321620
No abstract available.
9.
Kist J, Vos R, Mairuhu A, Struijs J, van Peet P, Vos H, et al.
EClinicalMedicine
. 2023 Mar;
57:101862.
PMID: 36864978
Background: Socioeconomic status and ethnicity are not explicitly incorporated as risk factors in the four SCORE2 cardiovascular disease (CVD) risk models developed for country-wide implementation across Europe (low, moderate, high...
10.
Kaptein F, Guman N, van Es N, Kamphuisen P, Klok F, Mairuhu A, et al.
Res Pract Thromb Haemost
. 2023 Feb;
7(1):100057.
PMID: 36846646
Background: In the recent years, numerous studies on the optimal treatment and prevention of cancer-associated venous thromboembolism (VTE) have been published, leading to updated (inter)national guidelines. These include direct oral...